The purpose of the study is to determine the frequency of systemic metastasis in node positive breast cancer following chemotherapy and surgery. Participants w…

Breast CancerNode-positive Breast Cancer

~Estimated

~$10 – $6,250

H. Lee Moffitt Cancer Center and Research InstituteNCT06833502

Phase 2

Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

This is a prospective radiation dose-finding, phase 2 expansion study of the Triple Negative (TN) cohort of the multicenter randomized study P-RAD (A Randomize…

Breast CancerTriple Negative Breast Cancer (TNBC)HER2-Negative Breast Carcinoma+1 more

~Estimated

~$10 – $6,250

UNC Lineberger Comprehensive Cancer CenterNCT07276880

Phase 2

SWIFT RT: Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer

In breast cancer patients with nodal involvement, numerous studies have demonstrated that adjuvant radiation therapy reduces the risk of local recurrence, regi…

Node-positive Breast Cancer

~Estimated

~$10 – $6,250

Washington University School of MedicineNCT06559540